CD45 expression by bone marrow plasma cells in multiple myeloma: clinical and biological correlations

[1]  E. van Marck,et al.  Angiogenic switch during 5T2MM murine myeloma tumorigenesis: role of CD45 heterogeneity. , 2004, Blood.

[2]  C. Huff,et al.  Characterization of clonogenic multiple myeloma cells. , 2004, Blood.

[3]  R. Bataille,et al.  Normal and malignant human plasma cells: proliferation, differentiation, and expansions in relation to CD45 expression. , 2004, Blood cells, molecules & diseases.

[4]  Shaji K. Kumar,et al.  Expression of CD52 on plasma cells in plasma cell proliferative disorders. , 2003, Blood.

[5]  R. Bataille,et al.  A cellular model for myeloma cell growth and maturation based on an intraclonal CD45 hierarchy , 2003, Immunological reviews.

[6]  K. Vanderkerken,et al.  Multiple myeloma tumor progression in the 5T2MM murine model is a multistage and dynamic process of differentiation, proliferation, invasion, and apoptosis. , 2003, Blood.

[7]  R. Fonseca,et al.  Prognostic value of angiogenesis in solitary bone plasmacytoma. , 2003, Blood.

[8]  N. Tsuyama,et al.  Interleukin-6, CD45 and the Src-Kinases in Myeloma Cell Proliferation , 2003, Leukemia & lymphoma.

[9]  R. Fonseca,et al.  Bone marrow angiogenesis in multiple myeloma: effect of therapy , 2002, British journal of haematology.

[10]  R. Fonseca,et al.  Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  N. Tsuyama,et al.  Requirements of src family kinase activity associated with CD45 for myeloma cell proliferation by interleukin-6. , 2002, Blood.

[12]  B. Pope,et al.  The bone marrow plasma cell labeling index by flow cytometry. , 1999, Cytometry.

[13]  H. Asaoku,et al.  MPC‐1−CD49e− immature myeloma cells include CD45+ subpopulations that can proliferate in response to IL‐6 in human myelomas , 1999, British journal of haematology.

[14]  T. Therneau,et al.  Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disorders , 1999, British journal of haematology.

[15]  H. Ishikawa,et al.  Induction of CD45 expression and proliferation in U-266 myeloma cell line by interleukin-6. , 1998, Blood.

[16]  D. Huhn,et al.  Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen , 1997, British journal of haematology.

[17]  R. Bataille,et al.  Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization. , 1995, Cancer research.

[18]  H. Harada,et al.  Identification of immature and mature myeloma cells in the bone marrow of human myelomas , 1993 .

[19]  A. Bloem,et al.  Lymphocyte function-associated antigen-1 expression on plasma cells correlates with tumor growth in multiple myeloma. , 1992, Blood.

[20]  P. Lacor,et al.  Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells , 1991, British journal of haematology.

[21]  J. Katzmann,et al.  Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  T. Habermann,et al.  Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies. , 1987, Mayo Clinic proceedings.

[23]  R. Bataille,et al.  Patients with CD45 negative multiple myeloma receiving high-dose therapy have a shorter survival than those with CD45 positive multiple myeloma. , 2004, Haematologica.

[24]  I. Trowbridge,et al.  CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. , 1994, Annual review of immunology.

[25]  L. Pilarski,et al.  Expression of multiple adhesion molecules on circulating monoclonal B cells in myeloma. , 1992, Current topics in microbiology and immunology.

[26]  M. Thomas,et al.  The leukocyte common antigen family. , 1989, Annual review of immunology.